These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36347937)

  • 41. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
    Galot R; Machiels JH
    Cancer Treat Rev; 2020 Apr; 85():101992. PubMed ID: 32092618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
    Solis RN; Silverman DA; Birkeland AC
    Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preclinical investigation of patient-derived cervical cancer organoids for precision medicine.
    Seol HS; Oh JH; Choi E; Kim S; Kim H; Nam EJ
    J Gynecol Oncol; 2023 May; 34(3):e35. PubMed ID: 36659831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomics and precision surgery for head and neck squamous cell carcinoma.
    Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
    Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Payne K; Pugh M; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ; Sun HH; Wang XT; Wang MT
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma.
    Shah PA; Huang C; Li Q; Kazi SA; Byers LA; Wang J; Johnson FM; Frederick MJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
    Liu S; Wang Y; Han Y; Xia W; Zhang L; Xu S; Ju H; Zhang X; Ren G; Liu L; Ye W; Zhang Z; Hu J
    Theranostics; 2020; 10(23):10589-10605. PubMed ID: 32929368
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine.
    Yang Y; Kong Y; Cui J; Hou Y; Gu Z; Ma C
    Stem Cell Rev Rep; 2024 Jul; 20(5):1213-1226. PubMed ID: 38532032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
    Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
    Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Oncogenic Targets by Tumor-Suppressive
    Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma.
    Ahn D; Lee GJ; Sohn JH; Lee JE
    Cancer Med; 2020 Dec; 9(24):9256-9265. PubMed ID: 33073917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in Head and Neck Squamous Cell Carcinoma.
    Bredel M; Kim H; Bonner JA
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Personalized cancer vaccination in head and neck cancer.
    Shibata H; Zhou L; Xu N; Egloff AM; Uppaluri R
    Cancer Sci; 2021 Mar; 112(3):978-988. PubMed ID: 33368875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pairing a prognostic target with potential therapeutic strategy for head and neck cancer.
    Lek SM; Li K; Tan QX; Shannon NB; Ng WH; Hendrikson J; Tan JWS; Lim HJ; Chen Y; Koh KKN; Skanthakumar T; Kwang XL; Chong FT; Leong HS; Tay G; Putri NE; Lim TKH; Hwang JSG; Ang MK; Tan DSW; Tan NC; Tan HK; Kon OL; Soo KC; Iyer NG; Ong CJ
    Oral Oncol; 2020 Dec; 111():105035. PubMed ID: 33091845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.